TCW Group’s Avidity Biosciences RNA Stock Holding History

TCW Group’s Portfolio RNA Stock Details RNA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell
2021 Q1	$310K	Sell
2020 Q4	$4.67M	Buy